Deferasirox-Induced Serious Metabolic Abnormalities; Bicalutamide-Induced Heart Failure; Combination Ipilimumab and Nivolumab–Induced Lethal Myocarditis; Polymyxin B-Trimethoprim Eye Drop–Induced Anaphylaxis; Methylphenidate-Induced Diffuse Maculopapular Rash

Autor:	Michael A. Mancano
Rok vydání:	2017
Předmět:	Pharmacology MedWatch Food and drug administration business.industry Medicine Pharmacology (medical) Pharmacy Medical emergency Drug reaction business medicine.disease Data science
Zdroj:	Hospital Pharmacy. 52:172-176
ISSN:	1945-1253 0018-5787
DOI:	10.1310/hpj5203-172
Popis:	The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: mmancano@temple.edu). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::35fbd889dc57942c06482846624d076d https://doi.org/10.1310/hpj5203-172 Zobrazit plný text záznamu